ALX Oncology Inc. (ALXO)
undefined
undefined%
At close: undefined
1.49
2.76%
After-hours Dec 13, 2024, 07:53 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue - - - 1.18M 4.80M 2.07M
Cost of Revenue 836.00K 1.47M 736.00K 1.07M 4.36M 1.88M
Gross Profit -836.00K -1.47M -736.00K 107.00K 436.00K 187.00K
Operating Income -170.28M -127.44M -83.56M -43.66M -19.18M -13.68M
Interest Income 10.65M 4.04M 91.00 124.00K 21.00 -
Pretax Income -160.81M -123.42M -83.48M -45.50M -19.21M -13.69M
Net Income -160.81M -123.48M -83.46M -45.74M -19.24M -13.73M
Selling & General & Admin 28.48M 29.04M 23.39M 14.81M 3.31M 2.60M
Research & Development 141.79M 98.40M 60.17M 28.96M 16.31M 11.27M
Other Expenses - -260.00K 84.00K -404.00K -5.00K -2.00K
Operating Expenses 170.28M 127.44M 83.56M 43.77M 19.62M 13.87M
Interest Expense 1.56M - 13.00K 811.00K 21.00K -
Selling & Marketing Expenses - - - - - -
Cost & Expenses 170.28M 127.44M 83.56M 44.84M 23.98M 15.75M
Income Tax - 64.00K -21.00K 241.00K 34.00K 45.00K
Shares Outstanding (Basic) 42.99M 40.70M 40.31M 39.84M 36.49M 21.95M
Shares Outstanding (Diluted) 42.99M 40.70M 40.31M 39.84M 36.49M 21.95M
EPS (Basic) -3.74 -3.03 -2.07 -1.15 -0.53 -0.63
EPS (Diluted) -3.74 -3.03 -2.07 -1.15 -0.53 -0.63
EBITDA -158.40M -121.95M -83.47M -43.46M -18.76M -13.26M
Depreciation & Amortization 836.00K 1.47M 736.00K 202.00K 429.00K 431.00K